Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Beginning Cash Balance (2011 - 2012)

Updated

Analysis

Northwest Biotherapeutics (NWBO) Beginning Cash Balance (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 150,000.00
Dec 31, 2011 73,000.00
API Access

Northwest Biotherapeutics Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=NWBO&period=max&api_key=YOUR_API_KEY